Brainstorm Cell Therapeutics Inc.
BCLI- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001137883
No open-market purchases or sales by Brainstorm Cell Therapeutics Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Brainstorm Cell Therapeutics Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 48 | 1 | 42 | −5 |
| Shares | 3.97M | 17.0K | 3.87M | −80.3K (−2.0%) |
| Value | $11.0M | $45.0K | $17.1M | +$6.18M (+56.4%) |
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (4)
Institutions that held Brainstorm Cell Therapeutics Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Tru Independence Asset Management 2, LLC | 44,000 | $194.0K | 0.21% |
| Creative Planning | 30,681 | $136.0K | 0.00% |
| Janney Montgomery Scott LLC | 20,000 | $88.0K | 0.00% |
| Marshall Wace, LLP | 13,024 | $58.0K | 0.00% |
Sold out (9)
Institutions that held Brainstorm Cell Therapeutics Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| JPMorgan Chase & Co | 187,070 | $516.0K |
| S.C. Financial Services, Inc. | 25,471 | $70.0K |
| Group One Trading, L.P. | 24,134 | $67.0K |
| Virtu Financial LLC | 20,702 | $57.0K |
| Susquehanna International Group, LLP | 15,323 | $42.0K |
| Jane Street Group, LLC | 12,085 | $33.0K |
| Tower Research Capital LLC (TRC) | 5,544 | $15.0K |
| First Manhattan Co | 500 | $1.00K |
| CoreCap Advisors, LLC | 133 | $0 |
Not filed for Q3 2022 yet (1)
Institutions that held Brainstorm Cell Therapeutics Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| HighPoint Advisor Group LLC | 17,033 | $45.0K |